CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top winning strategies, by year, 2015-2018*
3.2.4. Top winning strategies, by development, 2015-2018* (%)
3.2.5. Top winning strategies, by company, 2015-2018*

3.3. Porters five forces analysis
3.4. Top player positioning, 2016
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Increase in ageing population and rise in awareness towards surgical sealants and adhesives
3.5.1.2. Surge in prevalence of chronic diseases and rise in surgical procedures conducted globally
3.5.1.3. Surge in adoption of technologically advanced products

3.5.2. Restraints

3.5.2.1. High cost and extensive clinical data required for the launch of new surgical sealants and adhesives
3.5.2.2. Popularity of minimally invasive surgeries

3.5.3. Opportunity

3.5.3.1. Introduction of novel surgical sealants and adhesives and rise in healthcare spending

CHAPTER 4: SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT

4.1. Overview
4.2. Market size and forecast
4.3. Natural/biological surgical sealants and adhesives

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Natural/biological sealants and adhesives, by type

4.3.3.1. Market size and forecast
4.3.3.2. Polypeptide/protein-based sealants and adhesives

4.3.3.2.1. Market size and forecast
4.3.3.2.2. Fibrin based

4.3.3.2.2.1. Market size and forecast

4.3.3.2.3. Collagen based

4.3.3.2.3.1. Market size and forecast

4.3.3.2.4. Gelatin based

4.3.3.2.4.1. Market size and forecast

4.3.3.2.5. Albumin based

4.3.3.2.5.1. Market size and forecast

4.3.3.3. Polysaccharide-based sealants and adhesives

4.3.3.3.1. Market size and forecast
4.3.3.3.2. Chitosan based

4.3.3.3.2.1. Market size and forecast

4.3.3.3.3. Other polysaccharide based

4.3.3.3.3.1. Market size and forecast

4.3.4. Natural/biological sealants and adhesives, by origin

4.3.4.1. Market size and forecast
4.3.4.2. Human blood based

4.3.4.2.1. Market size and forecast

4.3.4.3. Animal based

4.3.4.3.1. Market size and forecast

4.3.4.4. Plant based

4.3.4.4.1. Market size and forecast

4.4. Synthetic & semisynthetic sealants and adhesives

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast
4.4.4. Cyanoacrylates

4.4.4.1. Market size and forecast

4.4.5. Polyethylene glycol-based hydrogel

4.4.5.1. Market size and forecast

4.4.6. Urethane-based adhesives

4.4.6.1. Market size and forecast

4.4.7. Other synthetic sealants and adhesives

4.4.7.1. Market size and forecast

CHAPTER 5: SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Central nervous system (CNS) surgeries

5.2.1. Market size and forecast, by region

5.3. General surgeries

5.3.1. Market size and forecast, by region

5.4. Cardiovascular surgeries

5.4.1. Market size and forecast, by region

5.5. Orthopedic surgeries

5.5.1. Market size and forecast, by region

5.6. Cosmetic surgeries

5.6.1. Market size and forecast, by region

5.7. Ophthalmic surgeries

5.7.1. Market size and forecast, by region

5.8. Urological surgeries

5.8.1. Market size and forecast, by region

5.9. Pulmonary surgeries

5.9.1. Market size and forecast, by region

5.10. Others

5.10.1. Market size and forecast, by region

CHAPTER 6: SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Tissue sealing & hemostasis

6.2.1. Market size and forecast, by region

6.3. Tissue engineering

6.3.1. Market size and forecast, by region

CHAPTER 7: SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by product
7.2.3. Market size and forecast, by indication
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country

7.2.5.1. U.S. market size and forecast
7.2.5.2. Canada market size and forecast
7.2.5.3. Mexico market size and forecast

7.3. Europe

7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by product
7.3.3. Market size and forecast, by indication
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country

7.3.5.1. Germany market size and forecast
7.3.5.2. UK market size and forecast
7.3.5.3. France market size and forecast
7.3.5.4. Italy market size and forecast
7.3.5.5. Spain market size and forecast
7.3.5.6. Rest of Europe market size and forecast

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by product
7.4.3. Market size and forecast, by indication
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country

7.4.5.1. Japan market size and forecast
7.4.5.2. China market size and forecast
7.4.5.3. India market size and forecast
7.4.5.4. Australia market size and forecast
7.4.5.5. South Korea market size and forecast
7.4.5.6. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by product
7.5.3. Market size and forecast, by indication
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country

7.5.5.1. Brazil market size and forecast
7.5.5.2. South Africa market size and forecast
7.5.5.3. Saudi Arabia market size and forecast
7.5.5.4. Rest of LAMEA market size and forecast

CHAPTER 8: COMPANY PROFILES

8.1. Baxter International Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. B. Braun Melsungen AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. Cohera Medical, Inc.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Key strategic moves and developments

8.4. CryoLife Inc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. C.R. Bard Inc.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance

8.6. CSL Limited (CSL Behring)

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. Johnson & Johnson (Ethicon, Inc.)

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. Ocular Therapeutix Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Business performance

8.9. Sanofi

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. Sealantis Ltd.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments